EP3765525
UNDIRSETT TVÍSÉRTÆKRA AND-HER2 MÓTEFNALYFJA-SAMTENGINGA OG NOTKUNARAÐFERÐIR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.3.2019EP published:
19.7.2023EP application number:
19766478.2
EP translation filed:
12.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
11.3.2039Expiry date:
11.3.2026Next due date:
31.3.2026
Title in English:
ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USELanguage of the patent:
English
Timeline
Today
12.3.2019EP application
19.7.2023EP Publication
12.10.2023Translation submitted
15.11.2023Registration published
11.3.2026Expires
Owner
Name:
Zymeworks BC Inc.Address:
Suite 800 - 114 East 4th Avenue, Vancouver, BC V5T 1G4, CA
Inventor
Name:
HAMBLETT, KevinAddress:
Vancouver, BC V5T 1G4, CA
Name:
DAVIES, Rupert H.Address:
Vancouver, BC V5T 1G4, CA
Name:
RICH, James R.Address:
Vancouver, BC V5T 1G4, CA
Name:
ROWSE, Gerald J.Address:
Vancouver, BC V5T 1G4, CA
Name:
FUNG, Vincent K. C.Address:
Vancouver, BC V5T 1G4, CA
Name:
BARNSCHER, Stuart D.Address:
Vancouver, BC V5T 1G4, CA
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201862642483 PDate:
13.3.2018Country:
US
Number:
201862658477 PDate:
16.4.2018Country:
US
Number:
201862743884 PDate:
10.10.2018Country:
US
Classification
Categories:
A61K 47/65, C07K 16/46, A61K 47/68, A61P 35/00, C07K 16/28, C07K 5/027, C07K 16/32
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 28.2.2024
Expires: 11.3.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 11.2.2025
Expires: 11.3.2026
Payer: Árnason Faktor ehf.